David Roman
Stock Analyst at Goldman Sachs
(0.92)
# 3,528
Out of 4,818 analysts
36
Total ratings
25%
Success rate
-10.45%
Average return
Main Sectors:
Stocks Rated by David Roman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KMTS Kestra Medical Technologies | Maintains: Neutral | $24 → $23 | $24.34 | -5.51% | 2 | Apr 16, 2025 | |
| HQY HealthEquity | Maintains: Neutral | $107 → $94 | $86.08 | +9.20% | 2 | Mar 27, 2025 | |
| GEHC GE HealthCare Technologies | Upgrades: Buy | $85 → $100 | $64.89 | +54.11% | 2 | Mar 11, 2025 | |
| ABT Abbott Laboratories | Maintains: Buy | $138 → $154 | $129.82 | +18.63% | 2 | Mar 4, 2025 | |
| TDOC Teladoc Health | Maintains: Buy | $16 → $13 | $7.07 | +83.88% | 3 | Mar 3, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Neutral | $42 → $24 | $16.57 | +44.84% | 2 | Mar 3, 2025 | |
| SOLV Solventum | Maintains: Sell | $63 → $71 | $65.90 | +7.74% | 4 | Mar 3, 2025 | |
| LIVN LivaNova | Maintains: Buy | $64 → $55 | $36.35 | +51.31% | 2 | Mar 3, 2025 | |
| BAX Baxter International | Reinstates: Buy | $42 | $29.65 | +41.65% | 3 | Feb 26, 2025 | |
| IRTC iRhythm Technologies | Maintains: Neutral | $91 → $124 | $102.93 | +20.48% | 2 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $58 → $80 | $54.24 | +47.49% | 2 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $384 → $427 | $357.11 | +19.57% | 2 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $81 → $90 | $70.46 | +27.73% | 3 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $90 | $98.87 | -8.97% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $500 | $487.93 | +2.47% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $274 | $202.51 | +35.30% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $129 | $99.54 | +29.60% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $83 | $83.72 | -0.86% | 1 | May 30, 2024 |
Kestra Medical Technologies
Apr 16, 2025
Maintains: Neutral
Price Target: $24 → $23
Current: $24.34
Upside: -5.51%
HealthEquity
Mar 27, 2025
Maintains: Neutral
Price Target: $107 → $94
Current: $86.08
Upside: +9.20%
GE HealthCare Technologies
Mar 11, 2025
Upgrades: Buy
Price Target: $85 → $100
Current: $64.89
Upside: +54.11%
Abbott Laboratories
Mar 4, 2025
Maintains: Buy
Price Target: $138 → $154
Current: $129.82
Upside: +18.63%
Teladoc Health
Mar 3, 2025
Maintains: Buy
Price Target: $16 → $13
Current: $7.07
Upside: +83.88%
Tandem Diabetes Care
Mar 3, 2025
Maintains: Neutral
Price Target: $42 → $24
Current: $16.57
Upside: +44.84%
Solventum
Mar 3, 2025
Maintains: Sell
Price Target: $63 → $71
Current: $65.90
Upside: +7.74%
LivaNova
Mar 3, 2025
Maintains: Buy
Price Target: $64 → $55
Current: $36.35
Upside: +51.31%
Baxter International
Feb 26, 2025
Reinstates: Buy
Price Target: $42
Current: $29.65
Upside: +41.65%
iRhythm Technologies
Feb 24, 2025
Maintains: Neutral
Price Target: $91 → $124
Current: $102.93
Upside: +20.48%
Feb 10, 2025
Maintains: Neutral
Price Target: $58 → $80
Current: $54.24
Upside: +47.49%
Jan 30, 2025
Maintains: Neutral
Price Target: $384 → $427
Current: $357.11
Upside: +19.57%
Dec 5, 2024
Maintains: Buy
Price Target: $81 → $90
Current: $70.46
Upside: +27.73%
May 30, 2024
Initiates: Buy
Price Target: $90
Current: $98.87
Upside: -8.97%
May 30, 2024
Initiates: Buy
Price Target: $500
Current: $487.93
Upside: +2.47%
May 30, 2024
Initiates: Buy
Price Target: $274
Current: $202.51
Upside: +35.30%
May 30, 2024
Initiates: Neutral
Price Target: $129
Current: $99.54
Upside: +29.60%
May 30, 2024
Initiates: Sell
Price Target: $83
Current: $83.72
Upside: -0.86%